`
`In re Patent of:
`
`Mitsutaka Nakamura. et a].
`
`US. Patent No.:
`Issue Date:
`
`Appl. Serial No.:
`Filing Date:
`
`9,815,827
`November 14. 2017
`
`14/471,919
`August 28. 2014
`AGENT FOR TREATMENT OF SCHIZOPHRENIA
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`US. Patent and 'l‘rademark ()l‘tice
`P.O. Box 1450
`
`Alexandria, VA 22313-1450
`
`PATENT OWNER’S POWER OF ATTORNEY IN AN INTER PAR TES REVIEW
`
`Patent Owner. Sumitomo Dainippon Pharma Co.. Ltd hereby appoints the following
`
`practitioners as its attorneys to transact all business in the United States Patent & Trademark
`
`Office associated with any inter partes review, covered business method review, post grant
`
`review, or other review proceedings before the Patent Trial and Appeal Board:
`
`Dorothy P. Whelan, Reg. No. 33,814
`
`W. Chad Shear, Reg. No. 47,938
`
`and all practitioners associated with PTO Customer Number 26171.
`
`I have the authority to execute this document on behalf of Sumitomo Dainippon Pharma
`
`Sumitomo Dainippon Pharma Co., Ltd
`
`Name: Hiroshi NOMURA
`
`Representative Director, President and CEO
`
`20114—6
`
`/2: 262/0
`
`